rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-3-20
|
pubmed:abstractText |
Human parvovirus B19 (B19) has been transmitted by various plasma-derived medicinal products. The aim of this study was to determine the frequency and the level of B19 DNA contamination in plasma pools destined for fractionation and in a broad range of plasma derivatives. In addition, removal of B19 DNA by the manufacturing process was investigated in cases where corresponding samples from plasma pool and product were available.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0042-9007
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
228-35
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11903998-Blood,
pubmed-meshheading:11903998-Blood Banks,
pubmed-meshheading:11903998-Blood Proteins,
pubmed-meshheading:11903998-Consumer Product Safety,
pubmed-meshheading:11903998-DNA, Viral,
pubmed-meshheading:11903998-Drug Contamination,
pubmed-meshheading:11903998-Humans,
pubmed-meshheading:11903998-Manufactured Materials,
pubmed-meshheading:11903998-Mass Screening,
pubmed-meshheading:11903998-Parvovirus B19, Human,
pubmed-meshheading:11903998-Polymerase Chain Reaction
|
pubmed:year |
2001
|
pubmed:articleTitle |
Parvovirus B19 DNA in plasma pools and plasma derivatives.
|
pubmed:affiliation |
Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, D-62335 Langen, Germany.
|
pubmed:publicationType |
Journal Article
|